首頁 > 美迪醫訊 > Research Report on Chinese Antihypertensive Drugs Market |
Research Report on Chinese Antihypertensive Drugs Market 【?2008-08-12 發布?】 美迪醫訊
Research Report on Chinese Antihypertensive Drugs MarketPublisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$3,100
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
1 Summary
2 Categories and market overview
2.1 CCB (calcium-channel blocker)
2.2 ACEI (angiotensin-converting enzyme inhibitor)
2.3 ARBs (angiotensin Ⅱ receptor blocker)
2.4 β-blocker
2.5 α-blocker
2.6 Diuretic
2.7 Others
3 Sales analysis of the past 4 years
3.1 Market scale and growth trend
3.2 Market share and change trend
3.2.1 Sales shares of different products of Antihypertensive Drugs
3.2.2 Sales shares of different products of CCB
3.2.3 Sales shares of different products of ACEI
3.2.4 Sales shares of different products of ARBs
3.2.5 Sales shares of different products of β-blocker
3.2.6 Sales shares of different products of α-blocker
3.2.7 Sales shares of different products of diuretic
3.2.8 Others
3.3 Change about sales rank of key brands
4 Market analysis of last year
4.1 Sales shares of different products
4.2 Sales shares of different brands
4.3 Key products and competitive enterprises of CCB
Amlodipine
Nifedipine
Felodipine
Nimodipine
levamlodipine
Nitrendipine
Nisoldipine
Others
4.4 Key products and competitive enterprises of ACEI
Benazepril
Enalapril
Captopril
Lysinopril
Ramipril
Compound Captopril
Others
4.5 Key products and competitive enterprises of ARBs
Losartan
Valsartan
Irbesartan
Telmisartan
Candesartan
Coumpand preparation
4.6 Key products and competitive enterprises of β-blocker
4.7 Key products and competitive enterprises of α-blocker
4.8 Key products and competitive enterprises of α-blocker
4.9 Key products and competitive enterprises of Diuretic
5 Sales analysi of key cities
6 Research and development in China
6.1 Lsit of Domestic marketd products and import procucts
6.2 Status of application and approval for Blood Thinning Drugs
本文關鍵字:
《美迪醫訊》歡迎您參與新聞投稿,業務咨詢: 美迪醫療網業務咨詢《上海醫療器械批發》產品推薦
|
合作支持:中華醫學會 | 中華醫院管理學會 | 國家食品藥品監督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫學裝備協會 |
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網站地圖 |
把美迪網放進收藏夾 把美迪醫療網介紹給我的朋友 給美迪醫療網留言
美迪醫療網廣告業務聯系:021-51601230 產品咨詢業務聯系:021-51601230 傳真:021-56532303 美迪醫療網業務咨詢 互聯網藥品信息服務許可證:(滬)-經營性-2009-0003 中華人民共和國電信與信息服務業務經營許可證:(滬)B2-20090029 滬ICP備14001091號-8 公安備案號 31010602000199 醫療器械經營許可證: 滬靜藥監械經營許20210003號 第二類醫療器械經營備案憑證: 滬靜藥監械經營備20220042號 營業執照:統一社會信用代碼91310108676284138X互聯網藥品信息服務資格書:(滬)-非經營性-2023-0081 |